Shortage outlook · all drugs · read October 2026
How long has Flurazepam Hydrochloride been on the FDA shortage list?
Flurazepam Hydrochloride has been on the FDA shortage list for 4 years and 2 months. 72 of the 397 listings measured since 2014 lasted at least that long. Of the 72 past listings that reached the same age, 87% were still listed 6 months later (58 listings measured), 79% were still listed 12 months later (52 listings measured) and 58% were still listed 24 months later (32 listings measured). These are counts of listings, not a forecast.
Compiled by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). FDA list read October 2026.
Flurazepam Hydrochloride has been on the FDA shortage list for 4 years and 2 months (September 2022 to October 2026).
- 72 of the 397 listings measured since 2014 lasted at least that long.
- Of the 72 past listings that reached the same age, 87% were still listed 6 months later (58 listings measured), 79% were still listed 12 months later (52 listings measured) and 58% were still listed 24 months later (32 listings measured).
- Flurazepam Hydrochloride has been listed 2 times since 2014: earlier listings lasted 1 year and 8 months.
- None of this predicts an end date. A listing ends when the FDA removes it, which reflects supply across the whole country, and says nothing about one pharmacy's shelf.
The listing history, to scale
- Flurazepam Hydrochloride CapsulesListed May 2019 to December 2020 · 1 year and 8 months
- Flurazepam Hydrochloride CapsulesListed since September 2022 · 4 years and 2 months
What past listings of this age did
Of past listings that had already run 4 years and 2 months, how many were still listed later?
What the FDA list says about it today
Reasons companies gave: regulatory delay (2); 4 of 6 gave none. FDA category: Neurology; Other.
Company by company
Of 6 presentations, the companies reported 4 available, 0 with limited availability and 2 unavailable. This is each company's own report to the FDA, with the date of its last update.
- Rising Pharma Holdings, Inc.2 presentations · last updated 1 September 2026
- Chartwell Molecular Holdings LLC4 presentations · last updated 15 September 2026
FDA shortage list read October 2026 (monthly archived copies since 2014, rebuilt in the published dataset; current listing file read 11 November 2026). Listing is the FDA's status, not a statement about any pharmacy.
Where can you go from this result?
This result is one of 61 drugs on the list now. Open it in the lookup to search another drug, or read how the listings were measured.
- Remifentanil Hydrochloride52 months
- Mixed amphetamine salts (Adderall generics)48 months
- Etomidate48 months
- Sufentanil Citrate53 months
To check what is available now, ask your pharmacist, and see FDA drug shortage information and the FDA drug shortages database.